igf-1 lr3 pharmacokinetics IGF-1, the Cross Road of the Nutritional, Inflammatory and Hormonal Pathways to Frailty IGF-1LR3 | Research Peptide |
Description
Esopheal/Lung Cancer Multimodality
[DOI] [PubMed] [Google Scholar] Carro E, Trejo JL, Gerber A, Loetscher H, Torrado J, Metzger F, Torres-Aleman I
270, Mar
Surgical and interventional palliative treatment of upper gastrointestinal malignancies
Altering Potency of IGF-I In addition to enhancing retention of IGF-I in the ECM, the E-peptides may alter IGF-I receptor activation in other ways
In comparison, the IGF1-LR3 peptide analog appears to have a higher affinity to the anabolic insulin-like growth factor 1 receptors and binds less to serum proteins
